| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 15 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2020 | Grossi Federico53 | See Remarks | Sell | 856 | $30.21 | $25,859.76 | -2.7% | |
| Jun 15, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $30.21 | $151,050.00 | -0.5% | |
| Jun 15, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $30.21 | $75,525.00 | -0.4% | |
| May 15, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $29.92 | $149,600.00 | -0.4% | |
| May 15, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $30.00 | $75,000.00 | -0.4% | |
| May 8, 2020 | Fonteyne Paul R. | Director | Buy | 5,000 | $31.81 | $159,034.00 | New | |
| Apr 15, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $30.00 | $75,000.00 | -0.4% | |
| Apr 15, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $29.77 | $148,850.00 | -0.4% | |
| Mar 25, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $30.00 | $75,000.00 | -0.4% | |
| Mar 16, 2020 | Francois Cedric78 | Chief Executive Officer | Sale+OE | 35,637 | $21.32 | $759,934.22 | -0.5% |